Gout |
Chondrocalcinisis; Gout and Pseudogout; Hyperuricemia; Pseudogout |
Hyperuricemia is the presence of high levels of uric acid in the blood. The upper end of the normal range is 530 micromol/L (6 mg/dL) for women and and 619 micromol/L (7 mg/dL) for men. [1] Hyperuricemia is caused either by accelated generation of uric acid through purine metabolism or by impaired excretion in the kidney, or by high levels of fructose in the diet.[2][3] Humans lack urate oxidase, an enzyme which degrades uric acid. Increased levels predispose for gout and (if very high) ren ...
Wikipedia - [full article]
Gout Clinical Trials
- A Study Evaluating the Effect of of Etoricoxib and Indomethacin in the Treatment of Acute Gout.
ClinicalTrials.gov Identifier: NCT00142558 - Active, not recruiting
acute gout
- Assessing the Efficacy and Safety of Oral Febuxostat in Subjects With Gout
ClinicalTrials.gov Identifier: NCT00430248 - Active, not recruiting
Gout
- Safety and Efficacy Study of PEG-Uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout
ClinicalTrials.gov Identifier: NCT00325195 - Active, not recruiting
Gout
- A Study of Persons with Gout who Do Not Respond to or Are Allergic to Conventional Therapy
ClinicalTrials.gov Identifier: NCT00080210 - Completed
Gout
- Pegylated Recombinant Mammalian Uricase (PEG-uricase) as Treatment for Refractory Gout
ClinicalTrials.gov Identifier: NCT00111657 - Recruiting
Gout
- Febuxostat versus Allopurinol Control Trial (FACT) in Subjects with Gout
ClinicalTrials.gov Identifier: NCT00102440 - Completed
Gout
- Phase 3, Febuxostat, Allopurinol and Placebo-Controlled Study in Gout Subjects.
ClinicalTrials.gov Identifier: NCT00174915 - Completed
Gout
- Study to Assess the Long-Term Safety of Febuxostat in Subjects With Gout.
ClinicalTrials.gov Identifier: NCT00174941 - Completed
Gout
- Dose-Response, Safety and Efficacy Study of Oral Febuxostat in Subjects With Gout
ClinicalTrials.gov Identifier: NCT00174967 - Completed
Gout
- MPC-004 for the Treatment of an Acute Gout Flare
ClinicalTrials.gov Identifier: NCT00506883 - Completed
Gout
- Celebrex In Acute Gouty Arthritis Study
ClinicalTrials.gov Identifier: NCT00549549 - Not yet recruiting
Gout
- Validation Study of Physical Measurement of Tophi
ClinicalTrials.gov Identifier: NCT00175006 - Completed
Hyperuricemia; Gout
- Magnetic Resonance Imaging in Subjects With Gouty Tophi
ClinicalTrials.gov Identifier: NCT00174954 - Completed
Hyperuricemia; Gout
- Efficacy and Safety of Lumiracoxib 400 mg Once Daily in Acute Flares of Gout
ClinicalTrials.gov Identifier: NCT00170781 - Completed
Acute Gouty Arthritis
- Study of Allopurinol vs. Febuxostat in Subjects Completing the Phase 3 Trials C02-009 or C02-010.
ClinicalTrials.gov Identifier: NCT00175019 - Completed
Gout

Not Signed In -


